- Home
- SBI vs FBIO Comparison
SBI vs FBIO Comparison
Compare SBI & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBI | FBIO |
|---|---|---|
| Founded | 1992 | 2006 |
| Country | United States | United States |
| Employees | N/A | 78 |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.9M | 111.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SBI | FBIO |
|---|---|---|
| Price | $7.67 | $2.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 60.8K | ★ 694.0K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | ★ 4.52% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $55.22 |
| Revenue Next Year | N/A | $40.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.51 | $1.83 |
| 52 Week High | $8.01 | $4.53 |
Technical Indicators
Market Signals| Indicator | SBI | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 35.66 | 37.51 |
| Support Level | $7.58 | $2.31 |
| Resistance Level | $7.90 | $2.94 |
| Average True Range (ATR) | 0.08 | 0.20 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 29.41 | 14.56 |
Price Performance
Historical ComparisonAbout SBI Western Asset Intermediate Muni Fund Inc
Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.